CLDX: Celldex Therapeutics Inc Company Cash Volume

Brandmark of celldex.com (CLDX)

The clinical potential of new allergy-fighting antibodies serves as the primary growth catalyst for Celldex Therapeutics (CLDX), as evidenced by the company's free cash flow, where the current parameter equals 0.64. However, the business relies on external manufacturers, remaining dependent on their logistics. Risks are tied to testing uncertainty and competition. Liquidity dynamics help assess the balance between financial stability and capital efficiency.

CLDX - Celldex Corp Company Cash Reserve over the range 07/04/2022 - 11/21/2026

Financial and market metric breakdowns for Celldex (CLDX)

- stock value and consensus price forecast:
Summary company analysis:Celldex Therapeutics
Product sample of Celldex Therapeutics Inc

This indicator measures the volume of real liquid reserves to assess the business's ability to meet its obligations in the absence of revenue, serving as a fundamental stress-testing tool for financial stability. For the non-cyclical biopharma business of Celldex Therapeutics (CLDX), where development depends on clinical trials, the cash position confirms the autonomy of scientific assets from macroeconomics, determining the company's fundamental margin of safety.

Direct competitors

Company Cash Volume ARGX|BioNTech - Company Cash and Cash Equivalents|Company Cash Volume ABVX (abivax.com)|Company Cash Balance ADMA|Protagonist Therapeutics, Inc. - Company Cash Volume|Company Cash Reserve Immunovant, Inc.|KNSA: Company Cash Volume|GRFS - Company Liquid Assets|ADPT (Adaptive Biotechnologies Inc.) - Company Cash Volume|AUPH: Company Cash Balance|Company Cash Volume BCRX|VERA (Vera Pharma) - Company Cash Balance|Dianthus Pharma - Company Cash on Hand|Company Cash Balance PHVS|AbCellera Biologics - Company Cash Volume|Company Cash Balance TRML (Tourmaline Bio)|PGEN: Company Cash Volume|Company Cash Reserve Pharming Group N.V. (PHAR)|Company Cash Funds Nektar|upstreambio.com (UPB) - Company Liquid Assets|Company Cash Funds Zenas Bio (ZBIO)|Company Liquid Assets Immunome Inc|Company Cash Funds Gossamer Bio, Inc. GOSS|Company Cash Volume KalVista Pharmaceuticals Inc KALV|SEPN - Company Cash Funds|PVLA - Company Cash Volume|SVRA: Company Cash Volume|RIGL - Company Liquid Assets|ANAB (AnaptysBio Inc) - Company Cash Volume|Company Cash on Hand Astria Corp (ATXS)|Company Cash Volume ENGN|Company Liquid Assets rapt.com|Company Cash Volume JBIO (Aerovate Therapeutics Inc)|Company Liquid Assets Aclaris Therapeutics, Inc. (ACRS)|KYTX - Company Cash Funds|Company Liquid Assets Tiziana Life Sciences TLSA|CABA: Company Cash Volume|Company Cash and Cash Equivalents VTYX|Company Cash on Hand THTX|Company Cash Volume Avalo Therapeutics Inc.|Company Cash Funds Eledon (ELDN)|Company Cash Volume Agenus Inc (AGEN)|Company Cash Volume CLYM (climbbio.com)|ZURA - Company Cash on Hand|atyrpharma.com - Company Cash Volume|ADAG (adagene.com) - Company Cash and Cash Equivalents|IMA (Ikena Oncology) - Company Cash on Hand|Company Cash on Hand Shattuck Labs Inc|EQ (Equillium Inc) - Company Cash Volume|CNTB: Company Cash Balance|Company Cash Volume IMUX|ATRA (Atara Biotherapeutics, Inc.) - Company Cash Balance|Company Cash Volume IFRX (inflarx.de)|X4 Pharmaceuticals - Company Cash Funds|Adicet Bio, Inc. - Company Cash Volume|CELU (celularity.com) - Company Cash and Cash Equivalents|INMB: Company Cash Volume|Barinthus Biotherapeutics PLC (BRNS) - Company Cash Volume|Company Cash Funds Kezar Life Sciences|Company Cash on Hand SAB Biotherapeutics (SABS)|Company Cash Funds Akari Therapeutics Plc (AKTX)|Company Cash on Hand Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Company Cash on Hand|GeoVax Labs (GOVX) - Company Cash Reserve|edesabiotech.com - Company Cash Volume|Company Liquid Assets iBio Corp IBIO|CARM: Company Cash Volume|xtlbio.com (XTLB) - Company Cash Volume|BOLT (Bolt Biotherapeutics) - Company Cash Volume|Company Cash on Hand HCW Biologics (HCWB)|Company Cash on Hand APVO (Aptevo Therapeutics)|AIM - Company Cash Reserve|Aditxt - Company Cash on Hand|Company Cash Position gribio.com|XRTX: Company Cash on Hand|Company Cash Balance HIND (Vyome Holdings)|REVB (Revelation Bio) - Company Cash on Hand|Indaptus Corp (INDP) - Company Cash Volume|Company Cash Funds scinai.com|Company Cash on Hand CalciMedica, Inc. (CALI)|Company Cash Funds Affimed NV (AFMD)|Company Cash Funds ALLK (Allakos Inc)|Company Cash Funds HOOKIPA Pharma, Inc. HOOK|Company Liquid Assets IGM Bio (IGMS)|iTeos Pharma - Company Cash Volume|Company Liquid Assets oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Company Cash Funds|Company Cash and Cash Equivalents THRD